Last reviewed · How we verify
NCT04754438
Comparing the Efficacy of E-CBT to Mental Health Coaching for GAD
NA trial testing e-CBT in Anxiety in 96 participants. Completed in 30 December 2023.
30 December 2023
Quick facts
| Lead sponsor | Dr. Nazanin Alavi |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 96 |
| Start date | 1 April 2021 |
| Primary completion | 30 December 2023 |
| Estimated completion | 30 December 2023 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- e-CBT
- Mental Health Coaching
Conditions studied
- Anxiety — all drugs for Anxiety →
- Generalized Anxiety Disorder — all drugs for Generalized Anxiety Disorder →
Sponsor
Dr. Nazanin Alavi
Who can join
Adults 18 to 65, any sex, with Anxiety or Generalized Anxiety Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will compare the efficacy of an electronically-delivered cognitive behavioural therapy (e-CBT) program versus a mental health coaching program to treat generalized anxiety disorder (GAD). This randomized trial intervention will provide the e-CBT and mental health coaching for GAD through a secure, online platform. Participants will be between the ages of 18 and 65 years with a confirmed diagnosis of GAD according to the Diagnostic and Statistical Manual of Mental Disorders - 5th Edition (DSM-5). Participants will either be offered an e-CBT program tailored to GAD or an online mental health coaching program over 12 weeks to address their anxiety symptoms. e-CBT participants will complete pre-designed modules and homework assignments while receiving personalized feedback and asynchronous interaction with a therapist through the platform. Participants in the coaching group will be contacted weekly through the online platform's chat feature. Therapists will ask the participants a series of pre-designed questions that revolve around a different theme each week to prompt conversation. Using clinically validated symptomology questionnaires, the efficacy of the e-CBT program will be compared to the coaching group. These questionnaires will be completed at baseline, week 6, week 12, and at a 6-month follow-up. Questionnaires include the State-Trait Anxiety Inventory (STAI), the Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form (Q-LES-Q-SF), the Generalized Anxiety Disorder - 7 Item (GAD-7), and the Depression Anxiety Stress Scale - 42 Item (DASS-42).
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Comparing the Efficacy of Electronically Delivered Cognitive Behavioral Therapy (e-CBT) to Weekly Online Mental Health Check-Ins for Generalized Anxiety Disorder-A Randomized Controlled Trial: Comparaison de l'efficacité de la thérapie cognitivo-comportementale délivrée par voie
Chermahini MB, Eadie J, Agarwal A, Stephenson C, et al · · 2024 · cited 3× · PMID 39033431 · DOI 10.1177/07067437241261933 -
Comparing the Efficacy of an Electronically Delivered Cognitive Behavioral Therapy Program to a Mental Health Check-In Program for Generalized Anxiety Disorder: Protocol for a Randomized Trial.
Stephenson C, Kumar A, Malakouti N, Nikjoo N, et al · · 2023 · PMID 37587552 · DOI 10.2196/48899
Verify or expand the search:
- PubMed search for NCT04754438
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of e-CBT
Trials testing the same drug.
- NCT06865066 — Internet-Delivered Cognitive Behaviour Therapy for Women with Perimenopausal Anxiety · NA · recruiting
- NCT05648175 — Comparing Clinical Decision-making of AI Technology to a Multi-professional Care Team in ECBT for Depression · NA · recruiting
- NCT04747873 — Incorporating Stepped Care Approach Into e-CBT for Depression · NA · completed
- NCT04630197 — Using Online Delivered Therapy and Brain Imaging to Better Understand OCD · NA · completed
- NCT04478058 — Feasibility and Effectiveness of Delivering CBT Through OPTT for Depression · NA · completed
Other recruiting trials for Anxiety
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
- NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
- NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years · NA · recruiting
- NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
Other Dr. Nazanin Alavi trials
Trials by the same sponsor.
- NCT06865066 — Internet-Delivered Cognitive Behaviour Therapy for Women with Perimenopausal Anxiety · NA · recruiting
- NCT05648175 — Comparing Clinical Decision-making of AI Technology to a Multi-professional Care Team in ECBT for Depression · NA · recruiting
- NCT05579210 — Online Relapse Prevention Therapy for Patients With Alcohol Use Disorder · NA · completed
- NCT05754723 — Using an Online Psychotherapy Program and AI-assisted Interventions for Postsecondary Student Mental Health · NA · withdrawn
- NCT05125146 — Investigating the Effectiveness of E-CBTi Compared to Pharmaceutical Interventions in Treating Insomnia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04754438 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dr. Nazanin Alavi
- Last refreshed: 18 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04754438.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing